drugset / Trial / NCT01501214

Use of Atosiban in in Vitro Fertilization (IVF) Treatment

NCT01501214

RandomizedParallel-groupTriple-blindTreatment

Summary

The hypothesis of this randomized double blind study is that the live birth rates are significantly higher after the use of atosiban prior to the embryo transfer in patients undergoing in vitro fertilization (IVF) treatment. This study aims to compare the live birth rates of IVF treatment between patients receiving atosiban and placebo prior to the transfer.

Timeline

Start
2011-12
Primary completion
2013-12
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atosiban Other / unclassified 6 mg Intravenous

Indications